Overview
BioSpring is a contract manufacturing organization (CMO) based in Frankfurt, Germany, specializing in therapeutic oligonucleotide and mRNA synthesis since 1997. The company provides GMP-compliant manufacturing, analytical services, and quality control for antisense, siRNA, conjugates, and long single-stranded RNA applications across preclinical, clinical, and commercial stages. BioSpring operates cGMP cleanrooms and offers both small-scale and large-scale production with advanced LC-MS workflows and compliance-ready processes.
Frequently asked questions
- What types of oligonucleotides does BioSpring manufacture?
- BioSpring manufactures therapeutic oligonucleotides including antisense, siRNA, conjugates, and long single-stranded RNA for preclinical, diagnostic, and commercial applications. The company recently expanded capabilities to include next-generation oligonucleotides using Luxna's XNA technology, which offers improved binding affinity, increased stability, and reduced toxicity.
- What regulatory compliance and quality standards does BioSpring maintain?
- BioSpring operates cGMP-certified facilities with three independent cGMP cleanrooms for oligonucleotide manufacturing. The company provides GMP-compliant material and implements compliance-ready LC-MS workflows for analytical testing, ensuring regulatory compliance from early development through commercial production.
- What is BioSpring's manufacturing capacity and scale?
- BioSpring supports both small-scale and large-scale manufacturing with robust upstream and downstream processing capabilities. The company has undergone rapid expansion in recent years to meet growing demand for oligonucleotide synthesis and offers tailored solutions for projects at any development stage.